| Period | Period Low | Period High | Performance | |
|---|---|---|---|---|
| 1-Month | 442.720 +20.84% on 11/02/21 | | 621.000 -13.85% on 11/18/21 | +30.000 (+5.94%) since 10/29/21 |
| 3-Month | 442.720 +20.84% on 11/02/21 | | 621.000 -13.85% on 11/18/21 | -54.000 (-9.17%) since 08/27/21 |
| 52-Week | 411.000 +30.17% on 12/07/20 | | 680.000 -21.32% on 06/01/21 | +117.000 (+27.99%) since 11/27/20 |
New Data from SLN124 Healthy Volunteer Study Reinforce Broad Therapeutic Potential in Hematological Diseases Data presented at 2021 ASH annual meeting...
1 December 2021 LONDON, Silence Therapeutics plc, Nasdaq: SLN (“Silence” or “the Company”), a leader in the discovery, development and delivery of novel...
Silence Therapeutics Begins Exclusive Nasdaq Trading 30 November 2021 LONDON, Silence Therapeutics plc, Nasdaq:SLN ("Silence" or "the Company"), a...
Silence Therapeutics to Present at Jefferies London Healthcare Conference 11 November 2021 LONDON, Silence Therapeutics plc, AIM: SLN and Nasdaq: SLN...
Silence Therapeutics Welcomes Frazier Life Sciences as New Key Shareholder 5 November 2021 LONDON, Silence Therapeutics plc, AIM: SLN and Nasdaq: SLN...
Silence Announces Proposed Cancellation of Admission of its Ordinary Shares to Trading on AIM and Transition of its Primary Trading Venue to the Nasdaq...
Silence Therapeutics and Hansoh Pharma Announce Collaboration to Develop Therapeutics Leveraging Silence’s mRNAi GOLD™ Platform Hansoh will make a $16...
Silence Therapeutics to Host R&D Day on October 21, 2021 7 October 2021 LONDON, Silence Therapeutics plc, AIM: SLN and Nasdaq: SLN (“Silence” or “the...
Silence Announces Mallinckrodt Exercise of Options for Two Additional Complement Targets
| 3rd Resistance Point | 584.000 |
| 2nd Resistance Point | 565.000 |
| 1st Resistance Point | 550.000 |
| Last Price | 535.000 |
| 1st Support Level | 516.000 |
| 2nd Support Level | 497.000 |
| 3rd Support Level | 482.000 |
| 52-Week High | 680.000 |
| Fibonacci 61.8% | 577.242 |
| Fibonacci 50% | 545.500 |
| Last Price | 535.000 |
| Fibonacci 38.2% | 513.758 |
| 52-Week Low | 411.000 |